Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Sarah Lévesque"'
Autor:
Adrien Joseph, Guido Kroemer, Antoine Lafarge, Oliver Kepp, Jonathan Pol, Sylvere Durand, Marion Leduc, Pan Juncheng, Florine Obrist, Judith Michels, Maria Castedo, Allan Sauvat, Giulia Cerrato, Isabelle Martins, Ester Saavedra, Sijing Li, Sarah Lévesque, Fanny Aprahamian, Nitharsshini Nirmalathansan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/7714514c693442aeb5c3fe39dd25252e
Autor:
BOUCHARD, FRÉDÉRIC (AUTHOR)
Publikováno v:
Qui Fait Quoi. apr2024, Issue 438, p38-41. 4p. 7 Color Photographs.
Autor:
Francesca Castoldi, Juliette Humeau, Isabelle Martins, Sylvie Lachkar, Damarys Loew, Florent Dingli, Sylvère Durand, David Enot, Noëlie Bossut, Alexis Chery, Fanny Aprahamian, Yohann Demont, Paule Opolon, Nicolas Signolle, Allan Sauvat, Michaela Semeraro, Lucillia Bezu, Elisa Elena Baracco, Erika Vacchelli, Jonathan G. Pol, Sarah Lévesque, Norma Bloy, Valentina Sica, Maria Chiara Maiuri, Guido Kroemer, Federico Pietrocola
Publikováno v:
Cell Death Discovery, Vol 6, Iss 1, Pp 1-17 (2020)
Abstract Salicylate, the active derivative of aspirin (acetylsalicylate), recapitulates the mode of action of caloric restriction inasmuch as it stimulates autophagy through the inhibition of the acetyltransferase activity of EP300. Here, we directly
Externí odkaz:
https://doaj.org/article/87cf4e0d739f46b498bf36f527c63889
Autor:
Juliette Humeau, Allan Sauvat, Giulia Cerrato, Wei Xie, Friedemann Loos, Francesca Iannantuoni, Lucillia Bezu, Sarah Lévesque, Juliette Paillet, Jonathan Pol, Marion Leduc, Laurence Zitvogel, Hugues de Thé, Oliver Kepp, Guido Kroemer
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 5, Pp 1-22 (2020)
Abstract Chemotherapy still constitutes the standard of care for the treatment of most neoplastic diseases. Certain chemotherapeutics from the oncological armamentarium are able to trigger pre‐mortem stress signals that lead to immunogenic cell dea
Externí odkaz:
https://doaj.org/article/9ac05f98dda3489daa122aa6f33d4ae1
Autor:
Laura Carballeira Carrera, Sarah Lévesque-Daniel, Rahmeth Radjack, Marie Rose Moro, Jonathan Lachal
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Background: Cultural context substantially affects the experience and clinical expression of psychiatric diseases, while cultural factors limit both access to and effectiveness of care, especially for migrant families requiring specific types of serv
Externí odkaz:
https://doaj.org/article/a6e74d947ac14a51a3b2560cb3533b0d
Autor:
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, Juliette Paillet, Margerie Kremer, Francesca Castoldi, Elisa E. Baracco, Yan Wang, Erika Vacchelli, Gautier Stoll, Ariane Jolly, Pierre De La Grange, Laurence Zitvogel, Guido Kroemer, Jonathan G. Pol
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
We have recently shown that chemotherapy with immunogenic cell death (ICD)-inducing agents can be advantageously combined with fasting regimens or caloric restriction mimetics (CRMs) to achieve superior tumor growth control via a T cell-dependent mec
Externí odkaz:
https://doaj.org/article/10df4fd5ed474464b4a7ad18e64e5c28
Autor:
Sarah Lévesque, Jonathan G. Pol, Gladys Ferrere, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer
Publikováno v:
OncoImmunology, Vol 8, Iss 7 (2019)
Dietary interventions have a profound impact on whole body metabolism, including oncometabolism (the metabolic features allowing cancer cells to proliferate) and immunometabolism (the catabolic and anabolic reactions that regulate immune responses).
Externí odkaz:
https://doaj.org/article/32feab6ea8374c729987bdd993e0381e
Autor:
Wei Xie, Laura Mondragón, Brynjar Mauseth, Yan Wang, Jonathan Pol, Sarah Lévesque, Heng Zhou, Takahiro Yamazaki, Johannes J. Eksteen, Laurence Zitvogel, Baldur Sveinbjørnsson, Øystein Rekdal, Oliver Kepp, Guido Kroemer
Publikováno v:
OncoImmunology, Vol 8, Iss 7 (2019)
Local immunotherapies such as the intratumoral injection of oncolytic compounds aim at reinstating and enhancing systemic anticancer immune responses. LTX-315 is a first-in-class, clinically evaluated oncolytic peptide-based local immunotherapy that
Externí odkaz:
https://doaj.org/article/c7027c6c9390465c8e53155a4018a9e5
Autor:
Kristina Iribarren, Aitziber Buque, Laura Mondragon, Wei Xie, Sarah Lévesque, Jonathan Pol, Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Publikováno v:
OncoImmunology, Vol 8, Iss 3 (2019)
The treatment of breast cancer largely depends on the utilization of immunogenic chemotherapeutics, which, as a common leitmotif, stimulate the exposure of calreticulin (CALR) on the surface of cancer cells, thereby facilitating their recognition by
Externí odkaz:
https://doaj.org/article/ca61c5d614944afebb000f73416ddb1d
Autor:
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Oncolytic viruses selectively target and kill cancer cells in an immunogenic fashion, thus supporting the establishment of therapeutically relevant tumor-specific immune responses. In 2015, the US Food and Drug Administration (FDA) approved the oncol
Externí odkaz:
https://doaj.org/article/03d12639f3c548f790926fb8e9abd49a